Enliven Therapeutics Inc (NASDAQ: ELVN) established initial surge of 5.10% at $22.65, as the Stock market unbolted on Wednesday, before settling in for the price of $21.55 at the close. Taking a more long-term approach, ELVN posted a 52-week range of $13.30-$29.78.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 19.02%. Meanwhile, its Annual Earning per share during the time was 19.02%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -2.00%. This publicly-traded company’s shares outstanding now amounts to $59.23 million, simultaneously with a float of $41.91 million. The organization now has a market capitalization sitting at $1.34 billion. At the time of writing, stock’s 50-day Moving Average stood at $20.27, while the 200-day Moving Average is $20.15.
Enliven Therapeutics Inc (ELVN) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Enliven Therapeutics Inc industry. Enliven Therapeutics Inc’s current insider ownership accounts for 29.26%, in contrast to 76.04% institutional ownership. According to the most recent insider trade that took place on Oct 20 ’25, this organization’s CHIEF SCIENTIFIC OFFICER sold 12,500 shares at the rate of 22.08, making the entire transaction reach 276,025 in total value, affecting insider ownership by 915,188. Preceding that transaction, on Oct 17 ’25, Company’s PRESIDENT AND CEO sold 12,500 for 21.33, making the whole transaction’s value amount to 266,654. This particular insider is now the holder of 902,892 in total.
Enliven Therapeutics Inc (ELVN) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.5 per share during the current fiscal year.
Enliven Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -2.00% and is forecasted to reach -2.21 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -19.62% through the next 5 years, which can be compared against the 19.02% growth it accomplished over the previous five years trading on the market.
Enliven Therapeutics Inc (NASDAQ: ELVN) Trading Performance Indicators
Let’s observe the current performance indicators for Enliven Therapeutics Inc (ELVN). It’s Quick Ratio in the last reported quarter now stands at 32.58.
In the same vein, ELVN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.00, a figure that is expected to reach -0.43 in the next quarter, and analysts are predicting that it will be -2.21 at the market close of one year from today.
Technical Analysis of Enliven Therapeutics Inc (ELVN)
Now, what If we examine the latest scores posted by [Enliven Therapeutics Inc, ELVN]. During the last 5-days, its volume was better the volume of 0.4 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 70.10% While, its Average True Range was 67.87.
Raw Stochastic average of Enliven Therapeutics Inc (ELVN) in the period of the previous 100 days is set at 75.12%, which indicates a major fall in contrast to 92.08% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.00 that was lower than 1.24 volatility it exhibited in the past 100-days period.
